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Synaptosome-associated proteins SNAP-23/25, mem-
bers of a family of proteins essential for exocytosis, have
a highly conserved central cysteine-rich domain that
plays an important role in membrane targeting. More
than one cysteine in this domain is modified by palmitic
acid through a thioester linkage. In an effort to address
the biological significance of acylation of this domain,
we have generated synthetic peptides corresponding to
the cysteine-rich region of SNAP-23 and covalently mod-
ified the cysteines with palmitic acid. The interaction of
acylated and nonacylated peptides with lipid vesicles
and natural membranes has been investigated. Our re-
sults indicate that palmitoylation is essential for mem-
brane association. The palmitoylated peptides were able
to fuse both model and natural membranes. The extent
of fusion depended on the length of the peptides and the
number and positions of covalently linked palmitic ac-
ids. Peptide-mediated fusion was suppressed by lyso-
lipid and involved both outer and inner leaflets of the
lipid bilayer, which is characteristic of natural mem-
brane fusion. Our results suggest an important role for
the cysteine-rich palmitoylated domain of SNAP-23 in
promoting membrane fusion in cells.
The mixing of specific membrane compartments by the proc-
ess of fusion is a highly regulated event in eukaryotic cells. The
fusion process is exquisitely controlled in a manner that does
not disturb the structural and functional identity of organelles
(1, 2). Several proteins that are involved at different steps in
the transport process, from the formation of a transport vesicle
until its fusion with the target membrane, have been identified
(3–7). The SNARE1 proteins play a crucial role in the process of
intracellular membrane fusion. For fusion to occur, transport
vesicles with distinct v-SNAREs have to pair with cognate
t-SNAREs at the appropriate target membrane. Syntaxin and
SNAP-23/25 are members of the t-SNARE family of proteins,
whereas synaptobrevin/vesicle-associated membrane protein
are v-SNARE proteins (3–7).
Syntaxin, SNAP-25, and vesicle-associated membrane pro-
teins mediate fusion through the formation of helical bundles
that span opposing membranes. Hydrophobic C-terminal do-
mains anchor syntaxin and vesicle-associated membrane pro-
teins to the lipid bilayer of the plasma and vesicle membranes,
respectively. The crystal structure of the SNARE complex has
identified the regions of SNAP-25 that are involved in binary
and ternary interactions (8, 9). SNAP-25 and its non-neuronal
homolog, syndet/SNAP-23 (10, 11) possess cysteine residues
clustered in a relatively unstructured segment between two
helical domains. The cysteine residues in this segment are
palmitoylated (12–14). Mutants of syndet and SNAP-25 lacking
cysteines, and therefore not palmitoylated, are localized pre-
dominantly in the cytoplasm of transfected cells (15, 16). Based
on mutagenesis of SNAP-25, a minimal plasma membrane-
targeting domain composed of residues 85–120 has been iden-
tified. This segment has the ability to target green fluorescent
protein to plasma membranes in transfected cells (17). There
have been reports which suggest that cysteines and conse-
quently palmitoylation, are not essential for targeting of
SNAP-25 to membranes, as membrane association is facilitated
by syntaxin 1A (18). However, recent reports suggest that
membrane targeting of SNAP-25 is independent of interaction
with syntaxin 1A and the cysteine-rich domain is necessary for
function in intact cells (19).
To understand the role of the proposed membrane targeting
segment of the SNAP family of proteins in membrane assembly
of the parent protein and its possible role in the fusion process,
we have studied the interaction of synthetic peptides spanning
the cysteine-rich region of SNAP-23, with and without co-
valently linked palmitic acids, with model and natural mem-
branes. A schematic sketch showing the various domains of
SNAP-23, the primary structure of the segment with the cys-
teine cluster in SNAP proteins from different species, and the
synthetic peptides investigated in the present study are pre-
sented in Fig. 1, A and B. We observed that palmitoylation is
essential for the peptides to cause membrane fusion. Our re-
sults also provide insights into dependence of membrane fusion
on peptide length, position of cysteines, and extent of
palmitoylation.
EXPERIMENTAL PROCEDURES
Materials—Fmoc amino acids used in peptide syntheses were pur-
chased from Advanced Chemtech (Louisville, KY). All phospholipids
including those labeled with fluorescent tags were purchased from
Avanti Polar Lipids (Birmingham, AL). Calcein was from Sigma. All
other chemicals were of the highest grade commercially available.
Peptide Synthesis and On-resin Acylation—Peptides were synthe-
sized manually using solid phase procedures and Fmoc chemistry.
Cysteine sulfhydryl groups were blocked with acetamidomethyl group.
The N termini of peptides were acetylated in a mixture of acetic anhy-
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dride/triethylamine/dimethyl formamide (0.1:0:0.02:1, v/v). Palmitoyla-
tion was carried out as described before (20). Briefly, cysteine sulfhydryl
groups of resin-bound peptides were deprotected using 5 eq of mercuric
acetate (per cysteine) in dimethyl formamide for 1 h, followed by treat-
ment with 50 eq of -mercaptoethanol for another hour. The procedure
was repeated three times to ensure complete removal of acetamidom-
ethyl. On-resin palmitoylation of free –SH groups was carried out using
palmitic acid activated with N-hydroxybenzoatriazole and 2-(1H-benzo-
triazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate. Pep-
tides were cleaved from the resin purified by reverse phase high per-
formance liquid chromatography/reverse phase fast performance liquid
chromatography and characterized by matrix-assisted laser desorption
ionization-time of flight mass spectrometry. Expected mass was ob-
served for the nonpalmitoylated and palmitoylated peptides. Stock so-
lutions were made in trifluoroethanol or dimethyl sulfoxide. Peptide
concentration was determined by monitoring absorbance at 280 nm.
Preparation of Lipid Vesicles—Lipid vesicles with compositions PC,
PC:PE (1:1), PC:PE:SM:CL (1:1:1:1.5), and PC with 30 mol % choles-
terol were prepared by the extrusion method or by sonication. Lipid
stocks were diluted in chloroform to appropriate molar concentrations
and dried to form a thin film. The lipid films were left under vacuum
overnight to remove residual solvent and subsequently hydrated in 5
mM HEPES, pH 7.4, containing 150 mM NaCl. SUV were obtained by
sonication of the lipid suspension. LUV were obtained by extrusion
through polycarbonate filters of 100 nm pore size (21). For circular
dichroism studies, peptide was added to lipid solution in chloroform and
dried to form a mixed film. The film was hydrated and SUV were
prepared by sonication.
Fusion Assay in the Presence of Peptides—Resonance energy transfer
between NBD-PE (energy donor) and Rho-PE (energy acceptor) was
used to monitor membrane fusion (22). Two populations of liposomes
were prepared, one labeled with 2 mol % each of NBD-PE and Rho-PE
and the other unlabeled. The labeled and unlabeled vesicles were mixed
at a ratio of 1:9 to a final concentration of 200 M in 1.2 ml in 5 mM
HEPES containing 150 mM NaCl. Peptides were added and after 5 min,
fluorescence was recorded with excitation at 465 nm and emission set at
530 nm. The slit widths of the excitation and emission monochromators
were 5 nm. Percent fusion was calculated using the equation (F 
Fo)/(Ft  Fo)  100, where Fo  fluorescence intensity before adding
peptide, F  fluorescence intensity after adding peptide, and Ft 
fluorescence intensity after complete dilution by detergent (Triton
X-100). Fusion assays were done in the presence of 10 mM dithionite or
lysophosphatidylcholine (LPC) (23) as follows. The labeled vesicles were
incubated on ice for 1 h in the presence of 10 mM dithionite. Excess
dithionite was removed by passing through Sephadex G-50 spin col-
umns. To check the effect of LPC, 10 g/ml LPC was added to the
vesicles before recording the RET changes induced by the peptides.
Three independent experiments were carried out.
Binding of Peptides to Lipid Vesicles—Peptides (5 M) were titrated
with increasing amounts of lipid vesicles. The tryptophan fluorescence
was monitored with the excitation monochromator set at 280 nm, and
the emission spectrum was recorded from 320 to 400 nm with 5-nm slit
widths. All fluorescence measurements reported in this study were
done in a F-4500 Hitachi fluorescence spectrometer. The accessibility of
tryptophan to the aqueous quencher iodide in the presence of lipid
vesicles was determined as follows. KI was added in increasing
amounts from a 4 M stock containing 1 mM Na2S2O3. The data were
analyzed according to the Stern-Volmer equation, Fo/F  1  KSV[Q],
where Fo and F represent the fluorescence intensities in the absence
and presence of quencher [Q], respectively and KSV is the Stern-Volmer
quenching constant. Normalized accessibility factor was calculated
from the ratios of KSV at a lipid:peptide ratio of 50:1 and KSV for peptide
in the absence of lipid.
Circular Dichroism (CD) Spectroscopy—Spectra were recorded in a
JASCO J-715 spectropolarimeter in water and also in SUV composed of
PC:PE:SM:CL (1:1:1:1.5). Scanning was done in the wavelength range
FIG. 1. Schematic sketch of SNAP-23, sequences of the region
containing the cysteine cluster from various mammalian spe-
cies and peptides synthesized. A, sketch showing the highly con-
served coiled-coil domains of SNAP-23 and the cysteine cluster repre-
senting the palmitoylation sites. Sequences of human SNAP-23 and the
corresponding regions of SNAP proteins from various species within the
palmitoylation domain and the adjacent residues are indicated. The
conserved cysteine residues in the SNAP proteins are underlined. B,
sequence of the peptides synthesized. Cysteine residues that have been
palmitoylated are underlined. Corresponding nonpalmitoylated pep-
tides are denoted as 27C4, 27C2, Sc27C4, Sp27C4, 14C4, and 14C2,
respectively, and indicated in parentheses.
FIG. 2. Fusogenic activity of the palmitoylated peptides. A,
fusion of SUV and LUV by 27P4 at a peptide/lipid ratio 0.01. Lipid
composition of vesicles were: 1, PC:PE:SM:CL (1:1:1:1.5); 2, PC:PE
(1:1), 3, PC; 4, PC:CL (30 mol % CL). B, percent fusion of SUV and LUV
of lipid composition PC:PE:SM:CL (1:1:1:1.5) in the presence of various
peptides with increasing peptide/lipid ratios. SV-208 is a fusion peptide
derived from Sendai virus F1 protein. The sequence of the peptide is
IKLTQHYFGLLTAFGSNGTIG.
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of 195 to 250 nm. Path length was 1 mm. Data are represented as mean
residue ellipticity.
Content Leakage Assay—Lipid films formed after drying in vacuum
were hydrated in 70 mM calcein solution made in HEPES buffer, pH 7.4.
SUV were prepared by sonication. Untrapped calcein was separated by
gel filtration on a Sephadex G-75 column in 5 mM HEPES containing
150 mM NaCl and 5 mM EDTA, pH 7.4. Release of calcein on addition of
peptides was monitored with excitation at 490 nm and emission at 520
nm. Percent release was calculated from the equation (F  Fo)/(Ft 
Fo)  100, where Fo and F are fluorescence intensities in the absence
and presence of peptides and Ft is the fluorescence intensity after
adding Triton X-100.
Preparation of Pancreatic Zymogen Granules and Plasma Mem-
branes—Granules and membranes were isolated as described by Nadin
et al. (24). The precautions mentioned by Edwardson (25) were taken.
Granules from a single pancreas were suspended in 500 l of 5 mM MES
containing 280 mM sucrose, pH 6.0, 1 mM phenylmethylsulfonyl fluo-
ride, 1 g of pepstatin, and 1 mM EDTA was also included. Protein was
assayed by the Bradford method (26). Pancreatic membranes were
prepared by method of Meldolesi et al. (27). EDTA and pepstatin were
included in the buffers during processing. Membranes were resus-
pended in 5 mM MES containing 280 mM sucrose, pH 6.5, and stored in
aliquots at 20 °C at a protein concentration of 1 mg/ml. KCl-treated
membranes were prepared by incubating the membranes in 0.5 M KCl
for 30 min at 4 °C (25). Membranes were recovered by centrifugation at
70,000  g for 30 min. The pellets were resuspended in 0.5 M KCl and
the recovery step was repeated. The membrane pellet was washed in
sucrose/MES buffer and resuspended at a protein concentration of 1
mg/ml in the same buffer.
Fusion between Zymogen Granules and Pancreatic Plasma Mem-
branes—Membrane fusion was assayed by the measurement of relief of
self-quench of fluorescent probe R18 (28). 1 l of octadecylrhodamine
(R18) from a 20 mM stock solution in ethanol was added to 300 l of
granule suspension and incubated at 37 °C for 5 min. Granules were
collected by centrifugation at 900 g for 10 min and resuspended in the
original volume. In the fusion assay, 5 l of the granules (10 g of
protein) were resuspended in 600 l of MES buffer, pH 6.5, containing
1 mM phenylmethylsulfonyl fluoride, 1 mM dithiothreitol, 1 g/ml pep-
statin, and 280 mM sucrose. Fluorescence was recorded with excitation
at 560 nm and emission at 590 nm. After equilibration for 3 min, the
granules were challenged with target membranes (20 g of protein).
In the case of KCl-treated membranes, 30 g of protein was used.
Other components like peptides, Ca2, and EGTA were added to the
cuvette in accordance with the experimental requirement. Percent fu-
sion was calculated considering the fusion induced by 1 mM Ca2 as
100%.
Preparation of Resealed Ghosts—Red blood cells were isolated from
rat blood and resealed ghost membranes were prepared using the
method described by Mobley et al. (29). Phospholipid concentration of
the resealed ghosts was estimated by the Fiske-Subbarow method (30).
The ghost membranes were resuspended in incubation buffer (10 mM
sodium phosphate, pH 7.4, containing 120 mM KCl, 30 mM NaCl, and 1
mM EDTA). Fresh preparations were used in all the experiments.
Lipid Mixing between Red Cell Membranes—Lipid mixing was ana-
lyzed by measuring dequenching of R18 (29), by a procedure similar to
the zymogen granule plasma membrane fusion assay. Resealed ghost
membranes were incubated with R18 at a final concentration of 1 mol
of R18/50 mol of red cell lipid for 30 min at room temperature. Unbound
FIG. 3. Characteristics of peptide-mediated model membrane
fusion. A, effect of the addition of LPC (10 g/ml), an indicator for the
existence of a hemifusion intermediate on the fusogenic property of
peptides. Percent fusion induced by the palmitoylated peptides in the
presence and absence of LPC at peptide/lipid ratio 0.005 is shown. The
liposomes were composed of PC:PE:SM:CL (1:1:1:1.5). B, extent of inner
leaflet mixing upon bleaching of the outer leaflet NBD fluorescence by
10 mM dithionite is compared with the leaflet mixing in untreated
liposomes with composition as indicated in A. The peptide/lipid ratio
was 0.005. Inset, the initial NBD fluorescence intensity with and with-
out bleaching by dithionite. 60% reduction in initial NBD fluorescence
indicates complete bleaching of outer leaflet.
FIG. 4. Peptide association with model membranes monitored
by changes in tryptophan fluorescence. A, relative increase in the
tryptophan fluorescence of peptides upon titration with SUV with lipid
compositions PC (), PC:CL (), PC:PE (Œ), PC:PE:SM:CL (f). Lipid
ratios were as described in the legend to Fig. 2A. Nonacylated peptides
did not show any increase in tryptophan fluorescence, on titration with
lipid vesicles. B, accessibility of tryptophan to aqueous quencher (I).
The normalized accessibility factors (naf) were calculated as described
under “Experimental Procedures” from KSV of the peptides in the pres-
ence of liposomes composed of PC (), PC:CL (z), PC:PE (`), and
PC:PE:SM:CL (f).
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probe was removed by repelleting the ghosts at 22,000  g for 20 min
and washed in the incubation buffer. For the assay 50 M phospholipid
containing labeled and unlabeled ghosts at a molar lipid ratio of 1:4
were taken in incubation buffer. Fluorescence was recorded for 3 min
before the addition of peptides. Peptides were added and fluorescence
changes were monitored as a function of time. Fluorescence intensity of
intact R18-labeled red cell ghosts was 20–30% that of labeled ghosts
treated with 0.1% Triton X-100. Percent fusion was calculated using the
formula: 100  ((F  Fo)/(Fmax  Fo)), where F, Fo, and Fmax are the
fluorescence intensities before addition of peptide, after addition of
peptide, and after complete dilution of the probe by addition of 1%
Triton X-100.
RESULTS
Syntheses of Peptides—Peptides corresponding to 14 or 27
residues of the membrane-targeting domain of human
SNAP-23 were synthesized by solid phase methods. Four of the
five cysteines present in this domain are conserved in human
SNAP-25. In 27P4, the nonconserved cysteine was replaced
with phenylalanine, as observed in the sequence of human
SNAP-25 (Fig. 1). To generate peptides with two palmitic acids,
two cysteines were substituted with serines (27P2 and 14P2).
In Sc27P4, the cysteines at positions 6 and 8 that are present in
27P4 were exchanged with the amino acids at positions 18 and
24, to spread out the cysteines and examine whether their
clustering was important for activity. The amino acids after the
cysteine cluster in 27P4 were also scrambled (Sp27P4) with a
view to examine the role of this segment in membrane fusion.
Palmitoylation was carried out with peptides attached to the
resin after removal of the cysteine thiol protecting group.
Cleavage from the resin yielded the palmitoylated peptides. In
the 14-residue peptides, tryptophan was introduced at the N
terminus to facilitate quantitation as well as to monitor inter-
action with lipids by fluorescence spectroscopy.
Fusion of Liposomes—The ability of peptides to fuse lipid
vesicles of varying composition was examined by a fluores-
cence-dequenching assay (22) that monitors lipid mixing. In
this assay, NBD-PE and Rho-PE are present in “donor” lipo-
somes and fluorescence of NBD is quenched as a result of
energy transfer. When donor liposomes fuse with unlabeled
“acceptor” liposomes, the average distance between the fluoro-
phores increases, which results in an increase of NBD fluores-
cence. The ability of 27P4 to fuse SUV and LUV of varying lipid
composition is shown in Fig. 2A. Considerable fusion is ob-
served with vesicles composed of PC:PE:SM:CL. LUV fused
more effectively than SUV. Because maximum fusion was ob-
served with PC:PE:SM:CL vesicles, the fusogenic ability of
other peptides related to 27P4 was examined on SUV and LUV
with this composition. The data shown in Fig. 2B indicate that
27P4 causes maximum fusion. 27P2 and 14P4 show similar
extents of fusion, which is less than 27P4 but comparable with
Sc27P4. The shorter peptide with two palmitic acids causes
fusion to a considerably lower extent. The peptide Sp27P4 is
marginally less effective in causing fusion at high peptide con-
centrations as compared with 27P4. However, the extent of
fusion caused by Sp27P4 is more than the other peptides. The
four palmitic acids clustered at the N terminus appear to sig-
nificantly influence the fusogenic properties of the peptides. A
peptide corresponding to a segment of the Sendai virus F1
protein (IKLTQHYFGLLTAFGSNGTIG) that has been demon-
strated to induce fusion of lipid vesicles (31) is less efficient
than 27P4 and Sp27P4 in causing fusion.
Effect of Lysolipid on Membrane Fusion and Involvement of
Inner and Outer Leaflets—Hemifusion is an intermediate state
where the outer membrane leaflets mix to form a stalk struc-
ture (32–38). Biological membrane fusion is presumed to pro-
ceed through this state. Lysolipids stabilize positive curvature
upon integration in the outer leaflet because of their inverted
cone geometry (38). Because hemifusion is associated with cur-
vature of the outer leaflet, lysolipids are inhibitory to fusion
before membrane merger (37). We investigated whether pep-
tide-mediated fusion involved a hemifusion intermediate, and
the ability of the peptides to convert the hemifusion state to
complete fusion wherein the inner leaflet lipids of the fusing
membranes are also involved. The data presented in Fig. 3A
indicate reduction of fusion in the presence of LPC for all the
FIG. 5. Secondary structure of peptides. Circular dichroism spec-
tra of the peptides recorded in water () and lipid () vesicles composed
of PC:PE:SM:CL (1:1:1:1.5).
FIG. 6. Membrane permeabilization measured by the release
of entrapped calcein. A, percentage of calcein released by the palmi-
toylated peptides with an increasing peptide/lipid ratio from liposomes
with the composition PC:PE:SM:CL (1:1:1:1.5). B, percentage of calcein
release induced by peptide 27P4 at a peptide/lipid ratio 0.04 from
liposomes. 1, PC:CL; 2, PC; 3, PC:PE; 4, PC:PE:SM:CL. The ratios of the
various lipids are as described in the legend to Fig. 2A. Calcein release
was measured 5 min after addition of peptide. Beyond this time no
further release was observed.
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five peptides that cause fusion. This suggests hemifusion as a
possible step in the fusion process. To examine whether pep-
tide-mediated fusion involved both membrane leaflets, lipo-
somes where the fluorescence of NBD present in outer leaflet
was quenched by dithionite treatment, were used in the fusion
assay (39). A considerable amount of resonance energy transfer
was observed even after the quenching of outer leaflet fluores-
cence by dithionite (Fig. 3B). This shows that the peptides
induced lipid mixing in the inner leaflet along with the outer
leaflet. The efficiency of the inner leaflet mixing by these pep-
tides appears to be a little lower than the outer leaflet mixing.
Environment of Trp in the Presence of Lipid Vesicles—Be-
cause the fluorescence of Trp is sensitive to environment (40),
the fluorescence of Trp in synthetic peptides (described in Fig.
1) in the presence of lipid vesicles was monitored. All the
peptides have a single Trp residue. It was observed that the
nonpalmitoylated peptides when excited at 280 nm showed an
emission maximum at 350 nm in buffer. Addition of lipid ves-
icles did not result in change in the fluorescence properties
suggesting that the peptides do not bind to lipid vesicles. This
observation is also consistent with the inability of these pep-
tides to fuse lipid vesicles. Changes in fluorescence were ob-
served when lipid vesicles were added to the palmitoylated
peptides (Fig. 4A). A linear increase in F/Fo was observed for
14P2 with various lipids. For 27P2, Sp27P4, and Sc27P4, the
F/Fo plateaued at a lipid/peptide ratio of 20, whereas in 14P4
and 27P4, the plateau was observed at a ratio of 10. The data
indicate that the tetrapalmitoylated peptides with clustered
cysteines bind strongly to lipid vesicles irrespective of the na-
ture of the head group. The accessibility of Trp to iodide was
then examined. The data in Fig. 4B indicate that while Trp is
solvent exposed in the nonpalmitoylated peptides, it is shielded
for the aqueous quencher in the palmitoylated peptides. The
Trp is relatively less accessible in the palmitoylated 27-residue
peptides as compared with the 14-residue peptides. Despite
difference in the fusogenic properties, the Trp location seems to
be similar in 27P2, 27P4 and Sc27P4 and Sp27P4.
Conformation of Peptides—The conformations of the pep-
tides were examined in buffer and lipid vesicles (Fig. 5). The
palmitoylated peptides were not ordered in buffer and in the
presence of lipid vesicles showed minima at 208 and 222 nm,
which is characteristic of helical conformation (41). The non-
palmitoylated peptides did not show ordered structure in buffer
and lipid vesicles. These differences could arise as a result of
the palmitoylated peptides binding to lipid vesicles and lipid-
induced conformational changes in 27P2 and 27P4.
Leakage of Vesicle Contents—Whether the fusion process is
accompanied by leakage of vesicle contents was next examined.
FIG. 7. Fusion between zymogen
granules and plasma membranes. A,
membrane fusion monitored by de-
quenching of R18-loaded zymogen gran-
ules with pancreatic plasma membranes.
1, Ca2; 2, 27P4; 3, Sp27P4; 4, 27P2; 5,
Sc27P4; 6, 14P4; 7, SV208; 8, 27C4; 9,
control. Inset, fusion induced by peptide
27P4 in the presence or absence of 1 mM
EGTA. Percent fusion was calculated con-
sidering the fusion caused by Ca2 as
100%. The concentration of peptides and
Ca2 are 1 M and 1 mM, respectively. B,
dependence of fusion on peptide concen-
tration. In both A and B, the R18 fluores-
cence of zymogen granules was recorded
for 2 to 3 min, after which they were chal-
lenged with plasma membranes and other
components. The dip in the fluorescence
intensity arises from the addition of mem-
branes and various components during
the process of recording.
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The data presented in Fig. 6A indicate that a maximum release
of 40% was observed with 27P4. No further release was ob-
served beyond a peptide/lipid ratio of 0.03. Release of calcein as
a function of lipid composition was examined for 27P4 (Fig. 6B).
Unlike fusion, substantial release of calcein was also observed
with PC vesicles. Calcein release was less pronounced in the
presence of other palmitoylated peptides, which were less ef-
fective in causing fusion. However, concentrations of the pep-
tides at which there was discernible calcein release were higher
than the concentrations at which they induced leaflet mixing.
Fusion of Natural Membranes—The ability of the peptides to
fuse membrane vesicles with plasma membranes in vitro was
investigated using zymogen granules and pancreatic plasma
membranes. Their fusogenicity has also been compared with
that of Ca2, which has been shown to stimulate fusion be-
tween zymogen granules and plasma membranes in vitro (25,
28). The data shown in Fig. 7A indicate that 27-residue pep-
tides have the ability to fuse the granules to the plasma mem-
brane. Ca2 was more effective than the peptides in inducing
fusion. The extent of fusion caused by 27P4 and Sp27P4 was
similar. The shorter palmitoylated peptides as well as SV208
peptide did not cause fusion. When the extent of fusion was
normalized with respect to Ca2, 27P4 showed 50% fusion.
Fusion by 27P4 was similar in the absence and presence of
EGTA, indicating that peptide-mediated fusion was Ca2-in-
dependent. The dependence of fusion on peptide concentration
is shown in Fig. 7B. 27P4 and Sp27P4 showed similar extents
of fusion at various peptide concentrations used in the
experiment.
The relation between Ca2 and peptide-mediated fusion was
investigated (Fig. 8). Fusion mediated by Ca2 was observed to
be independent from peptide-mediated fusion. As shown in Fig.
8A, when fusion was initiated by peptide, addition of Ca2
resulted in an increase the membrane mixing to an extent
equal to that caused by Ca2 alone. But when fusion was
initiated by Ca2, no further increase in fusion was observed
with the addition of peptides. A possible explanation for this
observation could be that the Ca2-induced lipid mixing is the
maximum attainable for this system under the conditions of
the study and therefore addition of peptides could not result in
a further increase in the fusion. From the results shown in Fig.
8B, it was evident that Ca2-mediated fusion was inhibited by
EGTA, whereas addition of EGTA did not affect peptide-medi-
ated fusion. Ca2 was unable to increase lipid mixing in the
presence of EGTA. Thus, peptide- and Ca2-mediated fusion
are independent events. To examine whether peripherally
bound proteins are involved in the fusion process, the effect of
KCl treatment on fusion was investigated. The data shown in
Fig. 9 indicate that salt wash abrogates Ca2-mediated fusion
but not fusion caused by peptides. This further confirms that
Ca2- and peptide-induced fusion are independent events.
The fusogenic ability of synthetic peptides on other mem-
brane systems like red blood cell ghost membranes was inves-
tigated. The data shown in Fig. 10 indicate that the palmitoy-
lated 27-residue peptides also cause fusion of red blood cell
ghost membranes. In this system, the SV208 peptide also
causes fusion, although to a lower extent.
DISCUSSION
The fusion events in eukaryotic cells are orchestrated events,
which are finely tuned by interaction with various proteins of
the SNARE family (1–7). SNAP-23/25, a crucial player in the
fusion process (8, 9) is a fairly hydrophilic protein but mem-
brane-associated. The protein does not have equivalents of
“fusion peptide segments” that exist in viral fusion proteins
(42). However, it has multiple cysteine residues, which are
proximal to each other in a central domain. Continuous
stretches of cysteines are present in cysteine string proteins,
which are known to be involved in exocytosis (43). Most of these
cysteines are palmitoylated. In cysteine string proteins, the
cysteines and hence palmitoylation could be essential for mem-
brane targeting (43, 44). The role of cysteines and palmitoyla-
tion in the SNAP family proteins with respect to membrane
attachment and fusion is yet to be clearly elucidated. We have
investigated the membrane binding and the ability of peptides
corresponding to the cysteine-containing SNAP segment to
cause fusion of natural and model membranes.
Our studies indicate that palmitoylation is necessary for
binding to lipid vesicles. In the shorter 14-residue peptide, four
covalently linked palmitic acids are essential for fusion. The
27-residue peptide where the four cysteines are clustered
(27P4) caused maximum fusion. When the amino acids after
the cysteine cluster were scrambled, there was a slight de-
crease in the extent of fusion of model membranes but not
natural membranes. The peptide Sc27P4 with relatively evenly
spaced out cysteines was less effective in causing fusion and
the efficiency was comparable with that of 27P2 where only two
palmitic acids are present at the N terminus. Hence, it appears
that four palmitic acids linked to a cluster of cysteines is an
important determinant for perturbation of the lipid layer so as
FIG. 8. Effects of EGTA and Ca2 on peptide-induced fusion
between zymogen granules and plasma membrane. A, effect of
peptides on Ca2-induced fusion and effect of Ca2 on peptide-induced
fusion for 27P4 and 27P2. B, effect of addition of Ca2 on fusion
initiated by 27P2 and 27P4 in the presence of 10 mM EGTA. In both A
and B, the Ca2 and peptide concentrations are 1 mM and 1 M,
respectively. Control indicates the basal level of fusion between the
zymogen granules and plasma membranes. The experimental condi-
tions for recording R18 fluorescence were same as those mentioned in
the legend of Fig. 7. A second dip in the fluorescence intensity seen here
arises from the addition of peptides/Ca2 during the process of record-
ing. Arrows indicate the time at which the various components were
added.
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to promote vesicle fusion. All the acylated fusogenic peptides in
this study fused vesicles that had the lipid composition PC:PE:
SM:CL with a higher efficiency compared with lipid vesicles of
other compositions. This observation could be relevant as there
are reports that SNAREs might be clustered in sphingolipid
cholesterol rafts in polarized apical sorting (45, 46). This lipid
composition is also very close to natural synaptic vesicle mem-
brane composition and the model membranes composed of
these four lipids have been shown to exhibit optimized fuso-
genic capabilities (47).
The fusion process appears to proceed via a transient hemi-
fusion state as evident from sensitivity to lysolipid. Fusion also
involves both bilayer leaflets as indicated by bleaching of NBD
in the outer leaflet by dithionite. However, unlike fusion caused
by peptide mimics of SNARE (48) and vesicular stomatitis
virus-G protein transmembrane segments (23), Ca2 does not
potentiate the fusogenic property of 27P4. Even in the case of
fusion of zymogen granules to plasma membranes, the process
appears to be independent of Ca2 and also independent of
peripheral membrane proteins.
Although proteins play crucial roles in the regulation of
biomembrane fusion, the process requires coming together and
coalescence of lipid bilayers. The role of lipids in membrane
fusion has been addressed (49–51). Defects in membrane lipid
packing are necessary for interaction between the hydrophilic
regions of the bilayers. The 27- or 14-residue peptides are not
intrinsically hydrophobic and are quite different from viral
fusion peptides (42). They do not associate with lipid vesicles in
the absence of palmitoylation. Even on palmitoylation, the
peptide chain does not appear to span the lipid bilayer. Despite
these differences, the fusion process seems to follow the steps
proposed in the Stalk hypothesis (32–38), involving binding,
formation of a hemifusion intermediate, and complete fusion.
A direct role for SNARE proteins in membrane fusion has
emerged from studies where isolated SNARE proteins have
been reconstituted in model membranes. Formation of SNARE
complexes has been shown to be essential for this fusion (52–
54). Recently, the SNARE protein domains other than those
involved in ternary complex formation have been implicated to
be important for fusion (48). Palmitoylation of SNAP-25 in
neurites and PC 12 cells is dynamically regulated and the
degree of palmitoylation influences membrane binding (13).
Our results indicate that palmitoylated and nonpalmitoylated
peptides exhibit distinctive differences in membrane-binding
properties and ability to promote fusion of membranes. It is
therefore possible that the palmitoylation status of the cysteine
FIG. 9. Requirement of peripheral proteins on the plasma
membrane for peptide-induced and Ca2-induced fusion. A, fu-
sion induced by the peptides, 27P2, 27P4, and Ca2 prior to treatment
of the plasma membrane with KCl. The concentrations of the peptides
were 1 M and that of Ca2 and EGTA were 1 mM. B, fusion after
treatment of plasma membranes with 0.5 N KCl. The amount of Ca2,
EGTA, and the peptides used was the same as in A. Control indicates
the basal level of fusion between the zymogen granules and plasma
membrane. Experimental conditions for R18 fluorescence measure-
ments were the same as indicated in the legend to Fig. 7.
FIG. 10. Fusion between red blood cell ghost membranes in-
duced by peptides. A, peptides (2 M) were added to a suspension of
R18-labeled and unlabeled ghost membranes. Time-dependent changes
in R18 fluorescence are shown. 1, 27P4; 2, 27P2; 3, SV208; 4, 27C4, 5,
14P4; 6, 14C4, 7, control. Fusion (%) was calculated as described under
“Experimental Procedures.” B, peptide concentration-dependent fusion
between red blood cell ghost membranes.
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cluster of SNAP proteins could play a crucial role in regulating
membrane fusion in cells.
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